News
Latest News
More than 125 life science leaders and representatives from more than 65 companies joined the leading trade…
The relationship will support educational programs for all ages at the historic site
We are excited to announce NewYorkBIO’s new Incubator & Accelerator Membership tiers, created to empower…
In 2025, NewYorkBIO launched New York Bio Connect, a first-of-its-kind resource hub. Designed for…
The award celebrates innovation, economic impact, and leadership in New York City’s thriving life sciences…
New York’s leading life science advocacy association and economic development organizations develop resource…
Statement on Behalf of Jennifer Hawks Bland, CEO of NewYorkBIO
StatNews 07/10/2026
ARPA-H launches bespoke gene therapy push, Lilly and Novo to promote Bridge program, and more ...
07/09/2026
An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in ...
07/09/2026
AstraZeneca, Ionis report major trial failure, White House pushes for American drug manufacturing, ...
07/09/2026
Two years, six months, and 18 days have elapsed since Northwest Biotherapeutics submitted its brain ...
07/09/2026
AstraZeneca and Ionis reported a notable trial failure Thursday in a heart disease that's become an ...
07/09/2026
How a father’s quest may shape the future of rare disease gene therapy.
07/08/2026
It's not clear what conditions may make the list, but outside experts are watching it closely.
07/08/2026
Why longevity entrepreneur Bryan Johnson’s chronic disease is notoriously difficult to diagnose.
07/08/2026
Kailera's GLP-1 pill data raises concerns, FDA clears Vera autoimmune therapy, and more biotech ...